Daniel L. Flynn
2021
Compensation breakdown
| Non-Equity Incentive Plan | $165,485 |
|---|---|
| Option Awards | $2,103,820 |
| Salary | $468,520 |
| Stock Awards | $632,922 |
| Other | $11,600 |
| Total | $3,382,347 |
Flynn received $2.1M in option awards, accounting for 62% of the total pay in 2021.
Flynn also received $165.5K in non-equity incentive plan, $468.5K in salary, $632.9K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Daniel L. Flynn's compensation ranked 3,955th out of 12,415 executives tracked by ExecPay. In other words, Flynn earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,955 out of 12,415 | 68th |
Division Manufacturing | 1,619 out of 5,508 | 71st |
Major group Chemicals And Allied Products | 667 out of 2,378 | 72nd |
Industry group Drugs | 592 out of 2,099 | 72nd |
Industry Pharmaceutical Preparations | 413 out of 1,549 | 73rd |
Pay ratio
| Daniel L. Flynn's Pay | $3,382,347 |
|---|---|
| Median Employee's Pay | $290,520 |
| Pay Ratio | 12to 1 |
In 2021, the annual total compensation of Daniel L. Flynn was $3,382,347.
The annual total compensation of the median employee at Deciphera Pharmaceuticals was $290,520.
The ratio of Daniel L. Flynn's pay to the pay of median employee was therefore 12 to one.
Flynn's colleagues
We found four more compensation records of executives who worked with Daniel L. Flynn at Deciphera Pharmaceuticals in 2021.